13979 - Artificial Intelligence for Drug Design Modulübersicht
Module Number: | 13979 |
Module Title: | Artificial Intelligence for Drug Design |
Künstliche Intelligenz in der Medikamentenentwicklung | |
Department: | Faculty GW - Faculty of Health Sciences Brandenburg |
Responsible Staff Member: |
|
Language of Teaching / Examination: | English |
Duration: | 1 semester |
Frequency of Offer: | On special announcement |
Credits: | 4 |
Learning Outcome: | After successfully completing the module, students have insight into this exciting field of application for Artificial Intelligence (AI). They are able to acquire research literature and to present the topic orally as well as in a written report. |
Contents: | AI is revolutionizing drug design both for small molecule drugs - the prevalent drug modality - and novel modalities such as oligonucleotide therapeutics. Some of the progress has been achieved by transferring methods from established AI areas such as NLP. For other areas novel methodological developments were instrumental, with very exciting developments on the intersection between molecular dynamics and AI. The focus of the seminar will be on state-of-the-art methods and applications of AI in drug design for small molecule drugs and oligonucleotide therapeutics. |
Recommended Prerequisites: | Working knowledge of probability/statistics and modern machine learning methods. |
Mandatory Prerequisites: | None |
Forms of Teaching and Proportion: |
|
Teaching Materials and Literature: | A list of original literature will be made available at the beginning of the semester. |
Module Examination: | Continuous Assessment (MCA) |
Assessment Mode for Module Examination: |
|
Evaluation of Module Examination: | Study Performance – ungraded |
Limited Number of Participants: | 25 |
Part of the Study Programme: |
|
Remarks: |
|
Module Components: |
|
Components to be offered in the Current Semester: |